why are glp-1 drugs so expensive Weight loss drug cost: How much people willing to spend Do The Benefits of GLP-1

and other risk factors described in the Companys public filings available on SEDAR+ at www.sedarplus.ca

The ThinWorks Expert Support Team will be pleased to respond

Aleniglipron (Structure Therapeutics) -- Phase 2# Aleniglipron has produced the most competitive oral weight loss data to date: ACCESS: 11.3% placebo-adjusted weight loss at 36 weeks (120 mg) ACCESS II: 15.3% placebo-adjusted weight loss at 36 weeks (240 mg) Low-dose initiation (2.5 mg) significantly improved tolerability Phase 3 planned for mid-2026 At 36 weeks, aleniglipron's trajectory suggests it could approach injectable-level efficacy with longer treatment duration

In light of the recent observance of World Obesity Day on March 4, 2024, we aim to raise awareness about this matter and discuss some of the issues linked to medications for treatment of obesity

doi:10.1007/s100380170066